SANVEEX TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
SAN FRANCISCO — January 07, 2026 — Sanveex Global Health (NASDAQ: SVX), a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines, today announced that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference.
The presentation is scheduled for Wednesday, January 14, 2026, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). A live audio webcast of the presentation will be available on the Investors section of the Sanveex website at www.sanveex.com.
Sanveex continues to advance its pipeline of novel therapeutics targeting oncology and rare diseases. The company expects to share updates on its Phase 3 clinical trials and strategic outlook for the coming year during the conference.
About Sanveex
Sanveex is a global biopharmaceutical company dedicated to changing the lives of patients with severe diseases. We focus on scientific innovation to deliver transformative medicines.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements.